Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial - PubMed (original) (raw)
Clinical Trial
Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial
Catherine S C Bouman et al. Crit Care Med. 2002 Oct.
Abstract
Objective: To study the effects of the initiation time of continuous venovenous hemofiltration and of the ultrafiltrate rate in patients with circulatory and respiratory insufficiency developing early oliguric acute renal failure. The primary end points were mortality at 28 days and recovery of renal function.
Design: A randomized, controlled, two-center study.
Setting: The closed-format multidisciplinary intensive care units of a university hospital (30 beds) and a teaching hospital (18 beds).
Patients and interventions: A total of 106 ventilated severely ill patients who were oliguric despite massive fluid resuscitation, inotropic support, and high-dose intravenous diuretics were randomized into three groups. Thirty-five patients were treated with early high-volume hemofiltration (72-96 L per 24 hrs), 35 patients with early low-volume hemofiltration (24-36 L per 24 hrs), and 36 patients with late low-volume hemofiltration (24-36 L per 24 hrs).
Results: Median ultrafiltrate rate was 48.2 (42.3-58.7) mL.kg(-1).hr(-1) in early high-volume hemofiltration, 20.1 (17.5-22.0) mL.kg(-1).hr(-1) in early low-volume hemofiltration, and 19.0 (16.6-21.1) mL.kg(-1).hr(-1) in late low-volume hemofiltration. Survival at day 28 was 74.3% in early high-volume hemofiltration, 68.8% in early low-volume hemofiltration, and 75.0% in late low-volume hemofiltration (p =.80). On average, hemofiltration started 7 hrs after inclusion in the early groups and 42 hrs after inclusion in the late group. All hospital survivors had recovery of renal function at hospital discharge, except for one patient in the early low-volume hemofiltration group. Median duration of renal failure in hospital survivors was 4.3 (1.4-7.8) days in early high-volume hemofiltration, 3.2 (2.4-5.4) days in early low-volume hemofiltration, and 5.6 (3.1-8.5) days in late low-volume hemofiltration (p =.25).
Conclusions: In the present study of critically ill patients with oliguric acute renal failure, survival at 28 days and recovery of renal function were not improved using high ultrafiltrate volumes or early initiation of hemofiltration.
Comment in
- Continuous renal replacement therapies: potential for fluid-side bacterial contamination?
Kanagasundaram NS, Larive AB, Paganini EP. Kanagasundaram NS, et al. Crit Care Med. 2003 Jun;31(6):1889-90; author reply 1890-1. doi: 10.1097/01.CCM.0000071922.32527.F4. Crit Care Med. 2003. PMID: 12794450 No abstract available.
Similar articles
- Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Picetti E, Sagripanti S, Manini P, Andreoli R, Cabassi A. Fiaccadori E, et al. Crit Care Med. 2004 Dec;32(12):2437-42. doi: 10.1097/01.ccm.0000147687.06808.92. Crit Care Med. 2004. PMID: 15599148 - A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD. Reeves JH, et al. Crit Care Med. 1999 Oct;27(10):2224-8. doi: 10.1097/00003246-199910000-00026. Crit Care Med. 1999. PMID: 10548211 Clinical Trial. - Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units.
Brause M, Neumann A, Schumacher T, Grabensee B, Heering P. Brause M, et al. Crit Care Med. 2003 Mar;31(3):841-6. doi: 10.1097/01.CCM.0000054866.45509.D0. Crit Care Med. 2003. PMID: 12626994 - The big bang of hemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification!
Honore' PM, Joannes-Boyau O, Merson L, Boer W, Piette V, Galloy AC, Janvier G. Honore' PM, et al. Int J Artif Organs. 2006 Jul;29(7):649-59. doi: 10.1177/039139880602900702. Int J Artif Organs. 2006. PMID: 16874669 Review. - Blood and plasma treatments: high-volume hemofiltration--a global view.
Honoré PM, Joannes-Boyau O, Gressens B. Honoré PM, et al. Contrib Nephrol. 2007;156:371-86. doi: 10.1159/000102128. Contrib Nephrol. 2007. PMID: 17464148 Review.
Cited by
- Antimicrobial dosing in acute renal replacement.
Fissell WH. Fissell WH. Adv Chronic Kidney Dis. 2013 Jan;20(1):85-93. doi: 10.1053/j.ackd.2012.10.004. Adv Chronic Kidney Dis. 2013. PMID: 23265600 Free PMC article. Review. - Clinical approach to the patient with AKI and sepsis.
Godin M, Murray P, Mehta RL. Godin M, et al. Semin Nephrol. 2015 Jan;35(1):12-22. doi: 10.1016/j.semnephrol.2015.01.003. Semin Nephrol. 2015. PMID: 25795496 Free PMC article. Review. - [Acute kidney injury].
Schmid H, Schiffl H, Lederer SR. Schmid H, et al. Med Klin Intensivmed Notfmed. 2012 Mar;107(2):141-6. doi: 10.1007/s00063-012-0098-x. Epub 2012 Mar 23. Med Klin Intensivmed Notfmed. 2012. PMID: 22437194 Review. German. - The Japanese clinical practice guideline for acute kidney injury 2016.
Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y; Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee. Doi K, et al. Clin Exp Nephrol. 2018 Oct;22(5):985-1045. doi: 10.1007/s10157-018-1600-4. Clin Exp Nephrol. 2018. PMID: 30039479 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources